Integra Lifesciences Holdings's EBITDA per Share for the
three
months ended in Dec. 2023 was $0.94.
During the past 12 months, Integra Lifesciences Holdings's average EBITDA Per Share Growth Rate was -30.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -1.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 8.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 11.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Integra Lifesciences Holdings was 39.70% per year. The lowest was -32.90% per year. And the median was 11.70% per year.
Competitive Comparison
For the Medical Devices subindustry, Integra Lifesciences Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings 5-Year EBITDA Growth Rate Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Integra Lifesciences Holdings 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Integra Lifesciences Holdings (Integra Lifesciences Holdings) Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IART has been successfully added to your